AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net selling: insiders sold $329K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$329K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Mar 31, 2026
- 0 added, 1 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 5- Open
- $3.42
- 52-wk high
- $8.46
- High
- $3.58
- 52-wk low
- $2.10
- Low
- $3.32
- Prev close
- $3.39
- Mkt cap
- $391.2M
- Volume
- 1.77M
- Fwd P/E
- 8.6x
- Beta
- 0.84
- P/S
- 0.2x
- P/B
- 1.1x
- Profit margin
- -24.1%
- Op margin
- -1.3%
- ROE
- -67.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about EVH filings
Are insiders buying or selling Evolent Health Inc (EVH) stock?
Net selling: insiders sold $329K and bought $0 of EVH stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. $329K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was McCarthy, Daniel Joseph (PRESIDENT), who sold $329K. The latest filing was on Aug 28, 2026.
Which members of Congress have traded EVH recently?
None. No member of Congress disclosed a EVH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this EVH smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Sells/Trims (1)
- JC
JPMorgan Chase
$10.9M
trimmed
What insiders are doing
Sells (1)
- MD
Mccarthy Daniel Joseph
$329K
sold
How top traders are positioned
No tracked top-trader positions in EVH right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 10.0% below what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.10 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | -$0.11 / -$0.10Alpha Vantage | -10.00% miss | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | -$0.02 / $0.05Alpha Vantage | -$0.07 miss | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 24, 2026 | $0.08 / $0.05Alpha Vantage | +$0.03 beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $0.05 / $0.10Alpha Vantage | -50.00% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | -$0.17 / $0.08Alpha Vantage | -$0.25 miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | $0.06 / $0.10Alpha Vantage | -40.00% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 20, 2025 | -$0.02 / $0.01Alpha Vantage | -$0.03 miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | $0.04 / $0.34Alpha Vantage | -88.24% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 5, 2026, in 31 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -24.1%
- Forward P/E
- 8.62
- Market cap
- $391M
Valuation
- P/S0.19
- P/B1.07
Quality
- Operating margin-1.3%
- ROE-67.0%
- ROA-0.8%
Growth
- Beta0.84
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace